Terms: = Cervical cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1
5 results:
1. Gene Expression Analysis Identifies Novel Targets for cervical cancer Therapy.
Roszik J; Ring KL; Wani KM; Lazar AJ; Yemelyanova AV; Soliman PT; Frumovitz M; Jazaeri AA
Front Immunol; 2018; 9():2102. PubMed ID: 30283446
[TBL] [Abstract] [Full Text] [Related]
2. Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis.
Resch U; Cuapio A; Sturtzel C; Hofer E; de Martin R; Holper-Schichl YM
J Biol Chem; 2014 Sep; 289(36):25088-100. PubMed ID: 25056949
[TBL] [Abstract] [Full Text] [Related]
3. The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.
Hu M; Zheng J; Zhang L; Jiang L; You Y; Jiang M; Li H
DNA Cell Biol; 2012 Jul; 31(7):1167-73. PubMed ID: 22335172
[TBL] [Abstract] [Full Text] [Related]
4. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract] [Full Text] [Related]
5. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells.
Shi RX; Ong CN; Shen HM
Oncogene; 2004 Oct; 23(46):7712-21. PubMed ID: 15334063
[TBL] [Abstract] [Full Text] [Related]
